Skip to Content

ML P19 8 mg (Doxazosin Mesylate 8 mg)

Pill with imprint ML P19 8 mg is Green, Elliptical / Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Dava Pharmaceuticals Inc..

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ML P19 8 mg

Doxazosin mesylate 8 mg ML P19 8 mg
Doxazosin mesylate 8 mg ML P19 8 mg Front
Doxazosin mesylate 8 mg ML P19 8 mg Back
Doxazosin mesylate 8 mg ML P19 8 mg

Doxazosin Mesylate

Imprint:
ML P19 8 mg
Strength:
8 mg
Color:
Green
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dava Pharmaceuticals Inc.
National Drug Code (NDC):
67253-0383
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide